Inflammatory mediators in dengue virus infection: Circulating interleukin-12 and interferon-γ

Dengue Bulletin

Volumn 26, Issue , 2002, Pages 144-154

  Juffrie, M ^a   vd Meer, G M ^b   Veerman, A J P ^b   Thijs, L G ^b   Hack, C E ^b  

^a GADJAH MADA UNIVERSITY   (Indonesia)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Children; Dengue virus infection; Interferon gamma; Interleukin 12; Shock

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; PLASMA PROTEIN; PROTEIN P40; PROTEIN SUBUNIT;

ARTICLE; ASCITES; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENGUE; DENGUE VIRUS; FEMALE; HEMATOCRIT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PATHOGENESIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT;

BACTERIA (MICROORGANISMS); DENGUE VIRUS;

EID: 0141829219     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Halstead SB. Immunological parameters of togavirus disease syndrome. In: Schlesinger RW (ed) The togaviruses. New York: Academic Press, Inc. 1980: 107-173.
2. Sabin AB. Dengue. In: Rivers T, Horsfatt F(ed). Viral and rickettsial infections of man. Philadelphia: JB Lippincott Co, 1959: 361-373.
3. World Health Organization. Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control. World Health Organization 1997. Geneva.
4. Kurane I, Innis BL, Nisalak A et al. Human responses to dengue virus antigens. Proliferative responses and interferon-gamma production. J Clin Invest, 1989, 83:506-513.
5. Kurane I, Innis BL, Nimmannitya S et al. Activation of lymphocytes in dengue virus infections. High levels of soluble interleukin-2 receptor. soluble CD4, soluble CD8, interleukin-2, and interferon in sera of children with dengue. J Clin Invest, 1991, 88: 1473-1480.
6. Bukowski JF, Kurane I, Lai CJ et al. Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol, 1989, 63: 5086-5091.
7. Kurane I, Meager A and Ennis FA. Dengue virus specific human T cell clones. Serotype cross-reactive proliferation, interferon-gamma production, and cytotoxic activity. J Exp Med, 1989, 170: 763-775.
8. Arai K, Lee F, Miyajima A, Miyatake S, Arai N and Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem, 1990, 59:783-836.
9. Kobayashi M, Fitz L, Ryan M et al. Identification and purification of Natural Killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med, 1989, 170: 827-845.
10. Stern AS, Podlaski FJ, Hulmes JD et al. Purification to homogenecity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA, 1990, 87:6808-6812.
11. Wolf SF, Temple PA, Kobayashi M et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 1991, 146: 3074-3081.
12. Gubler U, Chua AO, Schoenhaut DS et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA, 1991, 88: 4143-4147.
13. Schoenhaut DS, Chua AO, Wolitzky AG et al. Cloning and expression of murine IL-12. J Immunol, 1992, 148: 3433-3440.
14. Velzing J. Groen J, Drouet MT et al. Induction of protective immunity against dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines. Vaccine, 1999; 17: 1312-1320.
15. Merck E. Hematological Laboratory Methods. GIT Verlag-Earnst Gieblre. Darmstadt, 1983: 21-22.27-32.
16. Nakamura K, Okamura H, Nagata K, Komatsu T and Tamura T. Purification of a factor which provides a constimulatory signal for gamma interferon production. Infect immun, 1993, 61: 64-70.
17. Heinzel FP, Rerko RM, Ling P, Hakimi J and Schoenhaut DS. Interleukin-12 is produced in vivo during endotoxema and stimulates synthesis gamma interferon. Infect Immun, 1994, 62: 4244-4249.
18. Hazelzet JA, Kornelisse RF, Van der Pouw Kraan TCTM, Joosten KFM, Van der Voort E, Van Mierlo G, Suur MH, Hop WCJ, De Groot R and Hack CE. Cytokine, 1997, 9: 711-716.
19. Orange JS, Wolf SF and Biron CA. Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol, 1994, 152: 1253-1264.
20. Kurane I, Innis BL, Nimmannitya S et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon in sera of children with dengue. J Clin Invest, 1991, 88: 1473-1480.
21. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL and Ennis FA. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis, 1999, 179: 755-762.
22. Kalayanarooj S, Vaughn DW, Nimmannitya S et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis, 1997, 176: 313-321.
23. Stolpen AH, Guinan EC, Fiers W and Pober JS. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial monolayers. Am J Pathol, 1986, 123: 16-24.
24. Pandita R, Pocsik E and Aggarwal BB. Interferon-γ induces cell surface expression for both types of tumor necrosis factor receptors. FEBS Lett, 1992, 312: 87-90.